The Eijkman Institute for Molecular Biology (PRBME) is following up on and supporting the development and preparation of Merah Putih vaccine seeds by .
Research to develop the Merah Putih (Red and White) vaccine for COVID-19 is a milestone in Indonesia's research and development sector, according to an .
The COVID-19 pandemic has wreaked havoc globally, including in Indonesia. It has claimed many lives, increased the health burden, and weakened economic .
The participants of the Merah Putih (Red and White) vaccine’s clinical trial will be observed for one year, lead researcher for the clinical trial at .
The first phase clinical trial of the domestically-produced Merah Putih vaccine is a huge leap for independent vaccine development in Indonesia, the National .